No Data
No Data
H.C. Wainwright Maintains Kiora Pharmaceuticals(KPRX.US) With Buy Rating, Maintains Target Price $10
Express News | HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target
Buy Rating on Kiora Pharmaceuticals Amid Promising Clinical Trials and Strong Financials
We Think Kiora Pharmaceuticals' (NASDAQ:KPRX) Healthy Earnings Might Be Conservative
Buy Rating on Kiora Pharmaceuticals: Strong Financials and Promising KIO-301 Progress
Kiora Pharmaceuticals Shares Rise After Q2 Loss Narrows
No Data